 |
PDBsum entry 2m2d
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Apoptosis
|
 |
|
Title:
|
 |
Human programmed cell death 1 receptor
|
|
Structure:
|
 |
Programmed cell death protein 1. Chain: a. Synonym: protein pd-1, hpd-1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: pdcd1, pd1. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
NMR struc:
|
 |
35 models
|
 |
|
Authors:
|
 |
V.Veverka,X.Cheng,L.C.Waters,F.W.Muskett,S.Morgan,A.Lesley, M.Griffiths,C.Stubberfield,R.Griffin,A.J.Henry,M.K.Robinson, A.Jansson,J.E.Ladbury,S.Ikemizu,S.J.Davis,M.D.Carr
|
|
Key ref:
|
 |
X.Cheng
et al.
(2013).
Structure and interactions of the human programmed cell death 1 receptor.
J Biol Chem,
288,
11771-11785.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
18-Dec-12
|
Release date:
|
27-Feb-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q15116
(PDCD1_HUMAN) -
Programmed cell death protein 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
288 a.a.
118 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
288:11771-11785
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure and interactions of the human programmed cell death 1 receptor.
|
|
X.Cheng,
V.Veverka,
A.Radhakrishnan,
L.C.Waters,
F.W.Muskett,
S.H.Morgan,
J.Huo,
C.Yu,
E.J.Evans,
A.J.Leslie,
M.Griffiths,
C.Stubberfield,
R.Griffin,
A.J.Henry,
A.Jansson,
J.E.Ladbury,
S.Ikemizu,
M.D.Carr,
S.J.Davis.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
PD-1, a receptor expressed by T cells, B cells, and monocytes, is a potent
regulator of immune responses and a promising therapeutic target. The structure
and interactions of human PD-1 are, however, incompletely characterized. We
present the solution nuclear magnetic resonance (NMR)-based structure of the
human PD-1 extracellular region and detailed analyses of its interactions with
its ligands, PD-L1 and PD-L2. PD-1 has typical immunoglobulin superfamily
topology but differs at the edge of the GFCC' sheet, which is flexible and
completely lacks a C″ strand. Changes in PD-1 backbone NMR signals induced by
ligand binding suggest that, whereas binding is centered on the GFCC' sheet,
PD-1 is engaged by its two ligands differently and in ways incompletely
explained by crystal structures of mouse PD-1·ligand complexes. The affinities
of these interactions and that of PD-L1 with the costimulatory protein B7-1,
measured using surface plasmon resonance, are significantly weaker than
expected. The 3-4-fold greater affinity of PD-L2 versus PD-L1 for human PD-1 is
principally due to the 3-fold smaller dissociation rate for PD-L2 binding.
Isothermal titration calorimetry revealed that the PD-1/PD-L1 interaction is
entropically driven, whereas PD-1/PD-L2 binding has a large enthalpic component.
Mathematical simulations based on the biophysical data and quantitative
expression data suggest an unexpectedly limited contribution of PD-L2 to PD-1
ligation during interactions of activated T cells with antigen-presenting cells.
These findings provide a rigorous structural and biophysical framework for
interpreting the important functions of PD-1 and reveal that potent inhibitory
signaling can be initiated by weakly interacting receptors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |